KARLA MUNOZ BALDERAS: Open Payments
NPI 1467962076 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 43 payments from 14 companies in 2025. Trend: 2023 $247 · 2024 $833 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $107 |
| Organon LLC | 5 | $97 |
| ABBVIE INC. | 4 | $87 |
| Janssen Biotech, Inc. | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
| PFIZER INC. | 3 | $65 |
| GENZYME CORPORATION | 2 | $65 |
| LEO Pharma Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $42 |
Products named: OPZELURA, DUPIXENT, VTAMA, BLU-U, TREMFYA, CIBINQO, BOTOX, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
